Backbone-Determined Antiarrhythmic Structure–Activity Relationships for a Mirror Image, Oligomeric Depsipeptide Natural Product
Journal of Medicinal Chemistry · 25.07.2024 · 67 (14) · 12205-12220
DOI: 10.1021/acs.jmedchem.4c00923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 03.07.2024. Verfasst von Madelaine P Thorpe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37235, United States. Hauptthemen laut MEDLINE: Depsipeptides, Ryanodine Receptor Calcium Release Channel, Biological Products, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, Pharmaceutical Research and Manufacturers of America Foundation.
Abstract (Originalsprache)
Cyclic oligomeric depsipeptides (COD) are a structural class within naturally occurring compounds with a wide range of biological activity. Verticilide is a COD (24-membered ring) that was identified by its inhibition of insect ryanodine receptor (RyR). We have since found that the enantiomer of verticilide (ent-verticilide, 1) is a potent inhibitor of mammalian RyR2, a cardiac calcium channel, and therefore a potential antiarrhythmic agent. Oddly, nat-verticilide does not inhibit RyR2. To further develop ent-verticilide as an antiarrhythmic, we explored potential SAR through systematic modification of the ester's functionality to both N-H and N-Me amides. The syntheses of these ent-verticilide-inspired analogs are detailed using a monomer-based platform enabled by enantioselective catalysis. Two analogs among 23 exhibited measurable reduction of calcium sparks in a functional assay of RyR2 activity. These findings illustrate the value of natural product-inspired therapeutic development, but the less-studied approach where the non-natural enantiomeric series harbors important SAR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee 37235, United States.
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37235, United States.
ORCID-Profile: Madelaine P Thorpe, Jeffrey N Johnston
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- Pharmaceutical Research and Manufacturers of America Foundation
Zitieren
APA
Thorpe, M. P., Blackwell, D. J., Knollmann, B. C., & Johnston, J. N. (2024). Backbone-Determined Antiarrhythmic Structure–Activity Relationships for a Mirror Image, Oligomeric Depsipeptide Natural Product. Journal of Medicinal Chemistry, 67(14), 12205-12220. https://doi.org/10.1021/acs.jmedchem.4c00923
Vancouver
Thorpe MP, Blackwell DJ, Knollmann BC, Johnston JN. Backbone-Determined Antiarrhythmic Structure–Activity Relationships for a Mirror Image, Oligomeric Depsipeptide Natural Product. Journal of Medicinal Chemistry. 2024;67(14):12205-12220. doi:10.1021/acs.jmedchem.4c00923
BibTeX
@article{Thorpe2024,
author = {Thorpe, Madelaine P and Blackwell, Daniel J and Knollmann, Bjorn C and Johnston, Jeffrey N},
title = {Backbone-Determined Antiarrhythmic Structure–Activity Relationships for a Mirror Image, Oligomeric Depsipeptide Natural Product},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {14},
pages = {12205--12220},
doi = {10.1021/acs.jmedchem.4c00923}
}
EUVIMED